Stocks · NSE India · Healthcare · India
SUNPHARMA.NS — Sun Pharmaceutical Industries
Sun Pharmaceutical Industries (SUNPHARMA.NS) is a healthcare stock listed on NSE India (India). At the close of September 29, 2026 it traded at 1,865 (+1.47% on the day), -3.3% over one month, -1.8% over three months, +18.4% over twelve months. The InvestMuse composite score is -38 on a −100 to +100 scale, a bearish read that ranks #1054 of about 1,221 assets. The strongest of its nine dimensions are Technical indicators (+24) and Momentum (+2); the weakest is Regime (hidden Markov model) (-75). Its volatility regime from the hidden Markov model is Cool.
The facts
| Last close | 1,865 (September 29, 2026) |
|---|---|
| 1 day / 1 month / 3 months / 12 months | +1.47% / -3.3% / -1.8% / +18.4% |
| 52-week range | 1,575 – 2,001 |
| Composite score | -38 / 100 · bearish view · rank #1054 |
| Volatility regime (HMM) | Cool |
| Support levels | 425.00, 590.00 |
| Resistance levels | 805.00, 1,700 |
The nine dimensions
Each dimension is scored from −100 to +100; the composite is their weighted blend. Composite of 9 dimensions; not a recommendation.
- Regime (hidden Markov model)-75
- Technical indicators+24
- Trend-12
- Support / resistance0
- Fundamentals0
- Sector edge0
- News sentiment0
- Momentum+2
- Chart patterns and zones-20
How this read is made
Every night InvestMuse scores about 1,221 stocks, crypto assets, currencies, commodities and indices on nine dimensions: a hidden Markov model regime, technical indicators, trend, support and resistance from price clustering, fundamentals, the gap to sector peers, news sentiment, momentum, and chart patterns with demand/supply zones and Fibonacci levels. Members race each other with $100,000 of play money, against five fictional fund managers and the InvestMuse algorithm.
Data as of September 29, 2026. Observations from public market data — not investment advice, not a recommendation to buy or sell.